Future developments may see this reduced even further; and through the development of point-of-care devices, perhaps enable the clinician to make the diagnosis directly at the bed-side [2,3].While pathogen microarrays and their utility in discovering emerging infectious diseases such as SARS have been described, technical problems related to accuracy and sensitivity of the assay prevent their rout